Avoro Capital Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,200,000	Closed	-$13.5M	–	47
2023 Q4	$13.5M	Hold	1,200,000	–	–	0.19%	39
2023 Q3	$9.01M	Hold	1,200,000	–	–	0.14%	40
2023 Q2	$10.6M	Hold	1,200,000	–	–	0.14%	39
2023 Q1	$9.98M	Hold	1,200,000	–	–	0.15%	35
2022 Q4	$11.5M	Hold	1,200,000	–	–	0.17%	35
2022 Q3	$9.72M	Hold	1,200,000	–	–	0.18%	34
2022 Q2	$6.78M	Hold	1,200,000	–	–	0.13%	37
2022 Q1	$6.72M	Hold	1,200,000	–	–	0.12%	42
2021 Q4	$5.28M	Sell	1,200,000 -470,000	-28%	-$2.07M	0.09%	40
2021 Q3	$15.7M	Hold	1,670,000	–	–	0.25%	40
2021 Q2	$12.2M	Hold	1,670,000	–	–	0.21%	39
2021 Q1	$10.4M	Hold	1,670,000	–	–	0.18%	43
2020 Q4	$12.4M	Hold	1,670,000	–	–	0.21%	37
2020 Q3	$10.1M	Hold	1,670,000	–	–	0.14%	43
2020 Q2	$13.9M	Buy	1,670,000 +564,001	+51%	+$4.71M	0.28%	39
2020 Q1	$6.57M	Hold	1,105,999	–	–	0.22%	38
2019 Q4	$7.17M	Hold	1,105,999	–	–	0.21%	28
2019 Q3	$5.32M	Hold	1,105,999	–	–	0.22%	29
2019 Q2	$4.42M	Hold	1,105,999	–	–	0.15%	30
2019 Q1	$5.36M	Hold	1,105,999	–	–	0.23%	29
2018 Q4	$7.06M	Buy	1,105,999 +83,333	+8%	+$532K	0.42%	26
2018 Q3	$8.39M	Hold	1,022,666	–	–	0.39%	32
2018 Q2	$10.7M	Buy	1,022,666 +750,000	+275%	+$7.85M	0.41%	34
2018 Q1	$3.28M	Buy	272,666 +66,666	+32%	+$803K	0.16%	43
2017 Q4	$2.73M	Buy	206,000 +139,334	+209%	+$1.84M	0.18%	38
2017 Q3	$731K	Buy	+66,666	New	+$731K	0.06%	37